Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Study of [C-11]NOP-1A and Hydrocortisone in Heavy Drinking AUD Subjects
NCT07612631Phase 1Recruiting
- Start
- Jun 2026
- Primary completion
- Jun 2031
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hydrocortisone in alcohol use disorder (AUD). Primary endpoints: Amygdala DELTA VT and Total number of negative ETG tests at 8 weeks. Started Jun 2026; status: recruiting.
02
Drugs
hydrocortisone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07612631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07612631.